Ira R. Katz, MD, PhD
- 5Articles
- 14.1KReads1
- 1998–2004Active
- 22Collaborators
- 592Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Ira R. Katz, MD, PhD, has published extensively on neuropsychiatric conditions including dementia, major depressive disorder, and tardive dyskinesia. His work focuses on pharmacological treatments for behavioral and psychological symptoms in dementia, safety of antidepressants in frail elderly populations, and therapeutic approaches to tardive dyskinesia. Katz’s research, appearing between 1998 and 2004, includes clinical trials evaluating medications such as risperidone, sertraline, venlafaxine, and donepezil. He has frequently collaborated with authors like Andrew Greenspan and Catherine J. Datto.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
